{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Effect of 0.12% Chlorhexidine Use for Oral Care on Ventilator-Associated Respiratory Infections: A Randomized Controlled Trial

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize the essential elements of the study methodology for analyzing the effect of CHX use for oral care on preventing respiratory infections in mechanically ventilated patients.
  2. Identify the characteristics of the groups of patients who participated in the study.
  3. Select the results of the study that have implications for preventive oral care of mechanically ventilated patients.

Learning Outcomes

Healthcare providers will demonstrate knowledge of a randomized controlled trial with a primary aim of comparing the effect of 0.12% chlorhexidine (CHX) use vs. control for oral care on preventing ventilator-associated pneumonia (VAP) and ventilator-associated tracheobronchitis (VAT) by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $21.95


  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: JTN0721B
Published: Jul/Aug 2021
Expires: 6/7/2024
Required Passing Score: 7/10 (70%)
Authors: Duygu Kes, PhD, RN; Tugba Aydin Yildirim, PhD, RN; Cuneyt Kuru, MD; Fatma Pazarlioglu, RN; Taner Ciftci, MD; Mehmet Ozdemir, PhD